Young for Neopharm

Published: 20-Jul-2004

NeoPharm has Gregory P. Young as the company's new president and ceo. Young succeeds James Hussey, who resigned from NeoPharm to pursue other opportunities.


NeoPharm has Gregory P. Young as the company's new president and ceo. Young succeeds James Hussey, who resigned from NeoPharm to pursue other opportunities.

Young brings to NeoPharm more than 20 years of experience as a senior executive in the pharmaceutical industry. Most recently, he was a corporate vice president at Baxter Healthcare Corporation (since 2001) and president of Baxter's Transfusion Therapies Division (since 1999). Prior to these positions, he served in sales, marketing, and product development roles within Baxter's medication delivery business. He also served as president of the Baxter's Electronic Infusion Division.

'Greg's strong pharmaceutical and healthcare industry experience made him the board's clear choice to lead the company into its next phase of growth,' said Erick Hanson, chairman of the board of directors of NeoPharm. 'NeoPharm is in the hands of an extremely accomplished, operationally focused leader.'

'I am extremely honoured to be the chief executive officer of NeoPharm,' said Young. 'I am looking forward to navigating NeoPharm through the process of growing from a purely research and development company into a leader in the biotechnology industry with commercially available cancer drugs. We will initially be focusing our efforts on completing enrollment of the PRECISE trial and achieving FDA approval for IL13-PE38QQR. We will also be exploring all available options and opportunities available to us to bring our other drug candidates to market.'

IL13-PE38QQR

IL13-PE38QQR is NeoPharm's experimental tumour-targeting drug for the treatment of glioblastoma multiforme, one of the most common and aggressive forms of malignant brain tumors. The drug, currently in a worldwide FDA Phase III clinical trial (the "PRECISE" trial), is NeoPharm's lead drug product candidate.

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now